<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01498159</url>
  </required_header>
  <id_info>
    <org_study_id>2011-0099</org_study_id>
    <secondary_id>R01DK091347</secondary_id>
    <nct_id>NCT01498159</nct_id>
  </id_info>
  <brief_title>Health Promoters and Pharmacists in Diabetes Team Management</brief_title>
  <official_title>Health Promoters and Pharmacists in Diabetes Team Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research evaluates a diabetes management intervention designed to improve medication
      adherence and intensify therapy to reach goals in blood sugar, blood pressure, and
      cholesterol levels. This study will determine the benefit and cost of adding community health
      promoters to pharmacist disease management services. If there is benefit, then this approach
      may help reduce the burden of diabetes and its related complications among minorities with
      diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many African-Americans and Latinos with diabetes do not achieve the recommended goals for
      normal blood sugar, blood pressure, or cholesterol level, placing them at high risk for
      complications. This study will evaluate the impact of a novel intervention designed to
      improve lifestyle behaviors and medication adherence, and intensify therapy to reach goals.
      The first component of the intervention includes a clinic-based pharmacist disease management
      program. The program includes detailed patient assessments, physician-approved treatment
      plans, patient education and support services to enhance medication adherence. In addition,
      this program includes intensification of medication therapy to improve blood sugar, blood
      pressure, and cholesterol levels to reach recommended goals. The second component of the
      intervention includes health promoters (HPs), or community-based lay health workers. Health
      promoters are commonly found in minority communities and provide assistance for individuals
      overcoming language, cultural, and other barriers to conventional health care services. They
      may provide autonomy support and solve problems related to medication adherence barriers.
      Furthermore, health promoters may complement pharmacist activities by improving access to
      medications, assisting in continuity of care with providers, monitoring response to therapy,
      and reinforcing educational messages. The proposed study will determine whether the addition
      of health promoters to clinic based pharmacist service delivery improves care. The study will
      involve the recruitment of 300 African-American and Latino adults with uncontrolled diabetes
      through the University of Illinois Medical Center in Chicago and randomization to one of two
      groups: (1) pharmacist management (Pharm) for 12 months; or (2) pharmacist management with HP
      support (Pharm+HP) for 12 months. Cross-over will occur at 12 months such that the Pharm
      group will be intensified by the addition of HP support and HP support will be phased out
      from the Pharm+HP group to assess maintenance. The specific aims include: (1) To evaluate the
      effectiveness of Pharm+HP compared with Pharm alone on diabetes behaviors (including healthy
      eating, physical activity, and medication adherence), hemoglobin A1c, blood pressure, and
      LDL-cholesterol levels; (2) To evaluate the maintenance of improved diabetes behaviors as
      well as clinical outcomes by phasing out HP support from the Pharm+HP group after year 1; (3)
      To evaluate the intensification offered by adding an HP after one year of Pharm alone; and
      (4) To evaluate the cost and cost-effectiveness of Pharm+HP and Pharm alone.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">January 2018</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemoglobin A1c</measure>
    <time_frame>24 months</time_frame>
    <description>Hemoglobin A1c</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diabetes Knowledge</measure>
    <time_frame>24 months</time_frame>
    <description>Diabetes Knowledge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Autonomous Self-Regulation</measure>
    <time_frame>24 months</time_frame>
    <description>Autonomous Self-Regulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived Competence</measure>
    <time_frame>24 months</time_frame>
    <description>Perceived Competence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Adherence</measure>
    <time_frame>24 months</time_frame>
    <description>Medication Adherence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>24 months</time_frame>
    <description>Body mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Self-Care Behaviors</measure>
    <time_frame>24 months</time_frame>
    <description>Diabetes Self-Care Behaviors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>24 months</time_frame>
    <description>Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healthcare Utilization</measure>
    <time_frame>24 months</time_frame>
    <description>Healthcare Utilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>24 months</time_frame>
    <description>Systolic Blood Pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>24 months</time_frame>
    <description>Diastolic Blood Pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL Cholesterol</measure>
    <time_frame>24 months</time_frame>
    <description>LDL Cholesterol</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">244</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Pharmacist + Health Promoter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive support from both a pharmacist and health promoter. Number of sessions will be determined by the study team member and patient.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pharmacist</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive support from pharmacist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pharmacist disease/medication management</intervention_name>
    <arm_group_label>Pharmacist + Health Promoter</arm_group_label>
    <arm_group_label>Pharmacist</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pharmacist-patient encounters</intervention_name>
    <arm_group_label>Pharmacist + Health Promoter</arm_group_label>
    <arm_group_label>Pharmacist</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pharmacist medication intensification and adherence support</intervention_name>
    <arm_group_label>Pharmacist + Health Promoter</arm_group_label>
    <arm_group_label>Pharmacist</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pharmacist communication with primary care physicians</intervention_name>
    <arm_group_label>Pharmacist + Health Promoter</arm_group_label>
    <arm_group_label>Pharmacist</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pharmacist documentation in electronic medical record</intervention_name>
    <arm_group_label>Pharmacist + Health Promoter</arm_group_label>
    <arm_group_label>Pharmacist</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Health promoter-patient encounters in-person or by phone</intervention_name>
    <arm_group_label>Pharmacist + Health Promoter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Health promoter medication and lifestyle support</intervention_name>
    <arm_group_label>Pharmacist + Health Promoter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Health promoter communication with pharmacists</intervention_name>
    <arm_group_label>Pharmacist + Health Promoter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Self-identified as Latino/Hispanic or African-American

          -  Verbal fluency in English or Spanish

          -  Age 21 or above

          -  History of type 2 diabetes (&gt; 1 year)

          -  Hemoglobin A1c â‰¥ 8.0% (within 1 year)

          -  Receives primary care at UIMC (&gt; 1 year)

          -  Taking at least one oral medication for diabetes or hypertension

        Exclusion Criteria:

          -  Unable to verbalize comprehension of study or impaired decision making (e.g.,
             dementia)

          -  Lives outside Chicago communities of recruitment (3+ months/year)

          -  Household member already participating in same study

          -  Plans to move from the Chicago area within the next year

          -  Pregnant or trying to get pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ben S Gerber, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lisa K Sharp, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Illinois Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ihrp.uic.edu/study/health-promoters-and-pharmacists-diabetes-team-management</url>
    <description>IHRP Study Description</description>
  </link>
  <reference>
    <citation>Gerber BS, Cano AI, Caceres ML, Smith DE, Wilken LA, Michaud JB, Ruggiero LA, Sharp LK. A pharmacist and health promoter team to improve medication adherence among Latinos with diabetes. Ann Pharmacother. 2010 Jan;44(1):70-9. doi: 10.1345/aph.1M389. Epub 2009 Dec 22.</citation>
    <PMID>20028957</PMID>
  </reference>
  <reference>
    <citation>Gerber BS, Rapacki L, Castillo A, Tilton J, Touchette DR, Mihailescu D, Berbaum ML, Sharp LK. Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes. BMC Public Health. 2012 Oct 23;12:891. doi: 10.1186/1471-2458-12-891.</citation>
    <PMID>23088168</PMID>
  </reference>
  <results_reference>
    <citation>Sharp LK, Tilton JJ, Touchette DR, Xia Y, Mihailescu D, Berbaum ML, Gerber BS. Community Health Workers Supporting Clinical Pharmacists in Diabetes Management: A Randomized Controlled Trial. Pharmacotherapy. 2018 Jan;38(1):58-68. doi: 10.1002/phar.2058. Epub 2017 Nov 30.</citation>
    <PMID>29121408</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2011</study_first_submitted>
  <study_first_submitted_qc>December 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2011</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Ben Gerber</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Pharmacists</keyword>
  <keyword>Community Health Aides</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

